TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 4 filers reported holding TRINITY BIOTECH INVT LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $16,377,000 | -26.4% | 23,515,000 | -20.3% | 0.01% | -40.0% |
| Q1 2020 | $22,256,000 | +0.1% | 29,515,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $22,223,000 | +7.7% | 29,515,000 | +5.4% | 0.01% | 0.0% |
| Q3 2019 | $20,642,000 | -2.4% | 28,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $21,158,000 | -2.2% | 28,000,000 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $21,630,000 | -1.0% | 28,000,000 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $21,840,000 | -2.5% | 28,000,000 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $22,403,000 | +62.1% | 28,000,000 | +64.7% | 0.01% | +42.9% |
| Q2 2018 | $13,818,000 | +144.7% | 17,000,000 | +142.9% | 0.01% | +133.3% |
| Q1 2018 | $5,646,000 | -3.1% | 7,000,000 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $5,828,000 | +81.3% | 7,000,000 | +75.0% | 0.00% | +100.0% |
| Q3 2017 | $3,214,000 | -1.7% | 4,000,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $3,269,000 | +0.2% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,264,000 | -3.7% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,391,000 | -14.9% | 4,000,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $3,987,000 | +7.5% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,709,000 | – | 4,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 48,000,000 | $38,917,000 | 1.50% |
| Wellesley Asset Management | 29,650 | $23,979,000 | 1.25% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 23,425,000 | $19,091,000 | 0.28% |
| LINDEN ADVISORS LP | 8,590,000 | $7,034,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 850,000 | $699,000 | 0.03% |
| Citadel Advisors | 4,000,000 | $3,264,000 | 0.00% |